5% stakes
Frazier Life Sciences Public Fund
Institution
- 5% stake reports
- 42
- 5% stake stocks
- 22
- Latest report
- 26/09/21
5% stake reports
| Stock | ||
|---|---|---|
| Aclaris Therapeutics ACRS09/21 | 5.4%7,879,943 sh | First report |
| Vor Biopharma VOR08/14 | 4.2%2,258,001 sh | −1.6pp |
| Braveheart Bio BRVE08/14 | 5.5%4,976,457 sh | First report |
| Attovia Therapeutics ATTO08/11 | 13.5%6,154,213 sh | First report |
| MBX Biosciences MBX08/10 | 11.7%5,243,421 sh | +0.0pp |
| Valneva VALN05/12 | 3.6%6,879,516 sh | First report |
| iBio05/12 | 5.7%1,953,467 sh | −3.0pp |
| Achieve Life Sciences ACHV04/24 | 6.5%6,625,788 sh | First report |
| Allogene Therapeutics ALLO04/23 | 4.7%16,205,306 sh | First report |
| Mereo BioPharma Group MREO02/13 | 0%0 sh | −4.1pp |
| Aura Biosciences AURA02/13 | 6.3%4,032,060 sh | +1.3pp |
| Palvella Therapeutics PVLA02/13 | 6%706,360 sh | +1.1pp |
| Xilio Therapeutics XLO02/13 | 6.7%4,676,472 sh | −3.2pp |
| Maze Therapeutics MAZE02/13 | 9%4,342,266 sh | +1.3pp |
| Macrogenics MGNX02/13 | 0%0 sh | −2.5pp |
| Vor Biopharma VOR25/12/19 | 5.8%2,258,001 sh | First report |
| iBio25/12/16 | 8.7%1,953,467 sh | First report |
| Trevi Therapeutics TRVI25/11/14 | 7%8,508,021 sh | −3.6pp |
| Phathom Pharmaceuticals PHAT25/11/04 | 8.6%5,985,327 sh | +0.0pp |
| MBX Biosciences MBX25/09/30 | 11.7%5,224,095 sh | −1.9pp |
